Diagnosis of Mental Disorders - Home



Substance-Related and Addictive DisordersSubstance Use Disorders and Substance-Induced DisordersEthical and Legal StandardsWhen working with clients that may be experiencing these types of disorders, it is important to know what is ethical and what is legal. For example, we must always assess the client’s safety and act when we feel as though the client may be harmful to himself/herself or others. If a client’s drug/alcohol use is causing harm to the client and to other people in society, then we should consider more intense treatments such as residential facilities or inpatient. If a client gives any indication that he/she is suicidal, we must talk with the client about ideation, plan of action, etc. From here, we must decide if the client is safe to go back home or if they should be hospitalized. We must take religion and culture into consideration as some religions idolize having a drink for celebrations, while others may be completely against it. With this class of disorders, we must consider many laws, such as if the drug is legal or illegal. An example of this would be that cannabis is legal in Colorado but is not legal in Ohio. We also must take age into consideration as it is legal for someone over the age of 21 to consume alcohol, but it is illegal for those younger than 21. In this case, what action do we take if a 14-year-old comes in with alcohol withdrawals? This is where we decide how intense treatment should be. Often, clients abuse more than one substance, so it is important that counselors be prepared to work concurrently with presenting concerns. Also, clients that abuse substances are at a risk for more legal consequences, such as possession (depending on the drug). Counselors need to take an integrated approach with these clients as clients with substance abuse are often comorbid with mental concerns, learning disabilities, and behavioral disorders. Finally, it is important that counselors integrate case management services to address other issues these clients may be facing, such as being homeless, physical health concerns, and legal consequences (Kress & Paylo, 2015).Alcohol Use Disorder (code is based off severity)Pages 490-497DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-A problematic pattern of alcohol use that leads to significant/clinical impairment or distress-occurring in a 12-month period.-The use of alcohol causes social and/or interpersonal problems.-There is a craving or strong desire for alcohol.-Continued use of alcohol, despite its effects.-Important activities are given up or reduced.-Could become physically hazardous form the use of alcohol.Tolerance: diminished effect with continued use of same amount of alcohol or a need for an increase amount to reach the same level of intoxication. Withdrawal: Alcohol is taken to avoid withdrawal symptoms or another substance similar.Differential Diagnosis:-Nonpathological use of alcohol-Sedative, hypnotic, or anxiolytic use disorder-Conduct Disorder in childhood and adult antisocial personality disorder-Drug/Alcohol ScreenNIDA Drug Use Screening Tool: Quick ScreenCRAFFT (Part A)Alcohol Use Disorders Identification Test-C (AUDIT-C (PDF, 41KB))Alcohol Use Disorders Identification Test (AUDIT (PDF, 233KB))CAGE-AID (PDF, 30KB)CAGE (PDF, 14KB)DAST-20: Adolescent version (PDF 1.2MB)-Genogram-Structured Interview-Unstructured Interview-Medical Detoxification-Residential Treatment-Outpatient-Based Treatments-Motivational Interviewing (MI)-Cognitive Behavioral Therapy (CBT)-Behavioral Self-Control Training (BSCT)-Twelve-Step Facilitation-Social Skills Training-Family Therapy-Psychopharmacotherapy (Benzodiazepines) can treat: (a) withdrawals (b) abstinence (c) cravingsSpecify if:-In early remission-In sustained remissionSpecify if:-In a controlled environmentSeverity:-Mild- 305.00 (F10.10) 2-3 symptoms-Moderate-303.90 (F10.20) 4-5 symptoms-Severe-303.90(F10.20)6 or more symptomsRisk and Prognostic Factors-Environmental-Genetic and Physiological-Course modifiersMales have higher rates.Higher Rates in American Region.Alcohol IntoxicationPages 497-499Coding Note: IDC-9-CM is 303.00IDC-10-CM is based on there is a comorbid alcohol use disorder.-If mild alcohol use disorder is comorbid, use ICD-10-CM code F10.129-If moderate alcohol use disorder is comorbid, use ICD-10-CM code F10/229-If there is no comorbid alcohol use disorder, use ICD-10-CM code F10.929.DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-Recent ingestion of Alcohol that causes problematic behavior or psychological changes.-These may include slurred speech, incoordination, unsteady gait, nystagmus, impairment in attention or memory, or stupor or coma.-These symptoms/signs are not described better by another medication condition, mental disorder, including intoxication with another substance.Differential Diagnosis-Other medical conditions such as neurological conditions-Sedative, Hypnotic, or Anxiolytic intoxication-Drug/Alcohol ScreenNIDA Drug Use Screening Tool: Quick ScreenCRAFFT (Part A)Alcohol Use Disorders Identification Test-C (AUDIT-C (PDF, 41KB))Alcohol Use Disorders Identification Test (AUDIT (PDF, 233KB))CAGE-AID (PDF, 30KB)CAGE (PDF, 14KB)DAST-20: Adolescent version (PDF 1.2MB)-Genogram-Structured Interview-Unstructured Interview-Time-If alcohol intoxication continues and the client starts to crave it and regularly consume it, further treatment would be needed.-Treatment would depend on how often the client was intoxicated. If the client were continually intoxicated, he/she would need motivational interviewing, cognitive behavioral therapy, social skills training, twelve step facilitation, outpatient treatment, residential.-The level of treatment all depends on the level of severity. Prevalence in college students.Risk and Prognostic Factors-Temperament-EnvironmentalThere used to be a higher rate in males, but there is no significant difference in males/females anymore.Some religions are highly against consumption of alcohol, such as Mormons, Muslims, etc. while some religions use alcohol to celebrate, such as Catholics and Jews.Alcohol WithdrawalPages 499-501Coding Note:The ICD-9-CM code is 291.81. -The ICD-10-CM code for alcohol withdrawal without perceptual disturbances is F10.239.-The ICD-10-CM code for alcohol withdrawal with perceptual disturbances is F10.232.DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-When there is a decrease use of alcohol that has been heavy and prolonged which cause the development two or more of the following:autonomic hyperactivity, increased hand tremor, insomnia, nausea or vomiting, transient visual, tactile, or auditory hallucination’s or illusions, anxiety, generalized tonic-clonic seizures, and/or psychomotor agitation.-The signs/symptoms previously mentioned cause clinically significant impairment in important areas of functioning.-Signs/Symptoms cannot be better described by another medical condition, mental disorder, including intoxication or withdrawal from another substance.-Clinical Institute Withdrawal Assessment of Alcohol (CIWA-Ar)-The Prediction of Alcohol Withdrawal Severity Scale?(PAWSS)-Medical Detoxification-Residential Treatment-Outpatient-Based Treatments-Motivational Interviewing (MI)-Cognitive Behavioral Therapy (CBT)-Behavioral Self-Control Training (BSCT)-Twelve-Step Facilitation-Social Skills Training-Family Therapy-Psychopharmacotherapy (Benzodiazepines) can treat: (a) withdrawals (b) abstinence (c) cravingsSpecify it:-With perceptual disturbancesMuch more common in the middle-class.Risk and Prognostic Factors-EnvironmentalOther Alcohol-Induced DisordersUnspecified Alcohol-Related Disorder – 291.9 (F10.99)DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-Symptoms are like that of an alcohol related disorder that cause clinically significant impairment in important areas of functioning predominate, but they do not meet the full criteria for any alcohol-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class.-Drug/Alcohol ScreenNIDA Drug Use Screening Tool: Quick ScreenCRAFFT (Part A)Alcohol Use Disorders Identification Test-C (AUDIT-C (PDF, 41KB))Alcohol Use Disorders Identification Test (AUDIT (PDF, 233KB))CAGE-AID (PDF, 30KB)CAGE (PDF, 14KB)DAST-20: Adolescent version (PDF 1.2MB)-Genogram-Structured Interview-Unstructured Interview-Treatment would be based on the level of severity.-In this diagnosis, the client is not meeting all criteria, so it would not be as severe as some as it would be if the full criteria were met.-Some considerations would be:-Outpatient-Based Treatments-Motivational Interviewing (MI)-Cognitive Behavioral Therapy (CBT)-Behavioral Self-Control Training (BSCT)-Family Therapy-Social Skills Training Caffeine-Related DisordersCaffeine Intoxication – 305.90 (F15.929)Pages 503-506DiagnosisAssessments TreatmentsSides NotesDiagnostic Criteria-When a recent consumption of caffeine (typically well more than 250 mg) causes restlessness, nervousness, excitement, flushed face, diuresis, insomnia, muscle twitching, tachycardia and so on.-These symptoms cause clinically significant impairment in important areas of functioning.-These symptoms are not better described by a medical condition or another mental disorder, including intoxication of a different/another substanceDifferential Disgnosis-Other mental disorders-Other Caffeine-Induced Disorders-Genogram DAST-20: Adolescent version (PDF 1.2MB)CRAFFTDrug Abuse Screen Test (DAST-10 (PDF, 168KB))CAGE-AID (PDF, 30KB)NIDA Drug Use Screening ToolCRAFFT (Part A)NIDA Drug Use Screening Tool: Quick Screen-Structured Interview-Unstructured Interview-Time-If caffeine intoxication continues and the client starts to crave it and regularly consume it, further treatment would be needed.-Treatment would depend on how often the client was intoxicated. If the client were continually intoxicated, he/she would need motivational interviewing, cognitive behavioral therapy, social skills training, twelve step facilitation, outpatient treatment, residential.-The level of treatment all depends on the level of severity.Prevalence is unclear.Risk and Prognostic Factors-Environmental-Genetic and PhysiologicalCaffeine Withdrawal – 292.0 (F15.93)Pages 506-508DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-This is a diagnosis that occurs when an individual consumes caffeine daily for a long time and then experiences symptoms such as headaches, fatigue/drowsiness, depression, flu-like symptoms, and a hard time concentrating after a reduction in their caffeine intake.-Three or more of those symptoms must occur within a 24-hour period of reducing the intake of caffeine.-These symptoms significantly impair important areas of functioning.-These symptoms cannot be better described or attributed to medical conditions or other mental disorders, including substance intoxication or withdrawal of another substances.Differential Diagnosis-Other medical disorders and medical side effects-I had a hard time finding assessments for this disorder. I feel as though I would have the client take assessments for other withdrawal disorders.-I would also use a structured and unstructured interview setting to gain more information about the signs, symptoms, and substances used.-The most common treatments for withdrawals is psychopharmacotherapy, specifically Benzodiazepines.-Motivational Interviewing might also be useful to help the client get through this time where he/she is experiencing difficult symptoms.-CBT-Behavioral Self-Control Training (BSCT)-Family TherapyRisk and Prognostic Factors-Environmental -TemperamentalCaffeine consumers who must fast for religious purposes could be at an increased risk.Most common in the United States.Unspecified Caffeine-Related Disorder – 292.9 (F15.99)Page 509DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-When signs/symptoms of another caffeine related disorder are present, and are causing significant impairment on important areas of functioning, but do not meet the full criteria for any specific caffeine related disorder.-Does not meet any of the disorders in the substance-related and addictive disorders class.DAST-20: Adolescent version (PDF 1.2MB)CRAFFTDrug Abuse Screen Test (DAST-10 (PDF, 168KB))CAGE-AID (PDF, 30KB)NIDA Drug Use Screening ToolCRAFFT (Part A)NIDA Drug Use Screening Tool: Quick Screen-Structured Interview-Unstructured Interview-Treatment would be based on the level of severity.-In this diagnosis, the client is not meeting all criteria, so it would not be as severe as some as it would be if the full criteria were met.-Some considerations would be:-Outpatient-Based Treatments-Motivational Interviewing (MI)-Cognitive Behavioral Therapy (CBT)-Behavioral Self-Control Training (BSCT)-Family Therapy-Social Skills TrainingCannabis Use Disorder (Code is based off severity)DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-Pattern of cannabis use, that is problematic, and leads to significant impairment of important functioning.-Occurring within a 12-month period.-Have a craving for cannabis-The us results in a failure to fulfil major obligations.-important activities are either reduced or given up cause of this use.-Two or more of the nine symptoms must occur.Tolerance-a need for increased amounts of cannabis to reach the same intoxication level-a diminished effect when using the same amount of cannabis Withdrawal-This will be seen later, in cannabis withdrawal (pgs. 517-518)Differential Diagnosis-Nonproblematic use of cannabis-other mental disorders-Biological tests for cannabinoid metabolitesDAST-20: Adolescent version (PDF 1.2MB)CRAFFTDrug Abuse Screen Test (DAST-10 (PDF, 168KB))CAGE-AID (PDF, 30KB)NIDA Drug Use Screening ToolCRAFFT (Part A)NIDA Drug Use Screening Tool: Quick Screen-Structured Interview-Unstructured Interview-Medical Detoxification-Residential Treatment-Outpatient-Based Treatments-Motivational Interviewing (MI)-Cognitive Behavioral Therapy (CBT)-Behavioral Self-Control Training (BSCT)-Twelve-Step Facilitation-Social Skills Training-Family Therapy-Psychopharmacotherapy (Benzodiazepines) can treat: (a) withdrawals (b) abstinence (c) cravingsSpecify if:-In early remission-In sustained remissionSpecify if:-In controlled environmentSeverity:-Mild 305.20(F12.10) presence of 2-3 symptoms-Moderate 304.30 (F12.20)presence of 4-5 symptoms-Severe 304.30 (F12.20)presence of 6 or more symptomsRisk and Prognosis Factors-Temperamental-Environmental-Genetic and physiologicalPages 509-516Cannabis Intoxication Pages 516-518The ICD-9-CM code is 292.89The ICD-10-CM code is based off whether there is a comorbid cannabis disorder and whether there are perceptual disturbances.CANNABIS INTOXICATINO, WITHOUT PERCEPTUAL DISTURBANCESICD-10-CM code if a mild cannabis use disorder is comorbid, is F12.129.ICD-10-CM code if a moderate cannabis use disorder is comorbid, is F12.229ICD-10-CM code if there are no comorbid cannabis use disorder is F12.929CANNIS INTOXIATION, WITH PERCEPTUAL DISTURBANCESICD-10-cm code if a mild cannabis use disorder is comorbid, is F12.122ICD-10-CM code if a moderate cannabis use disorder is comorbid, is F12.222ICD-10-CM code if there are no comorbid cannabis use disorder is F12.922DiagnosisAssessmentTreatmentsSide NotesDiagnostic Criteria-Recent use of Cannabis-Clinically significant impairment shortly after use-Conjunctival injection-increased appetite-Dry mouth-Tachycardia-At least two of the previously mentioned symptoms are present within 2 hours of use.-cannot be attributable to another medical condition and not better described by another mental disorder, including intoxication of another substance.Differential Diagnosis-Other substance intoxication-Other cannabis-induced disorderDAST-20: Adolescent version (PDF 1.2MB)CRAFFTDrug Abuse Screen Test (DAST-10 (PDF, 168KB))CAGE-AID (PDF, 30KB)NIDA Drug Use Screening ToolCRAFFT (Part A)NIDA Drug Use Screening Tool: Quick Screen-Structured Interview-Unstructured Interview-Treatment would vary on how often the client engages in intoxication.-The best treatment for the client would be time so the substance can wear off.-If the client continues to use the substance, the diagnosis could change from cannabis intoxication to cannabis use disorder in which more intense treatment would be needed, such as:-Medical Detoxification-Residential Treatment-Outpatient-Based Treatments-Motivational Interviewing (MI)-Cognitive Behavioral Therapy (CBT)-Behavioral Self-Control Training (BSCT)-Twelve-Step Facilitation-Social Skills Training-Family Therapy-Psychopharmacotherapy (Benzodiazepines) can treat: (a) withdrawals (b) abstinence (c) cravingsSpecify if:-With perceptual disturbancesCannabis Withdrawal – 292.0 (F12.288)Pages 517-519DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-Interruption of cannabis use that has been prolonged and heavy causing irritability/anger, nervousness or anxiety, sleep difficulty, decreased appetite, depressed mood, restlessness, sweating, fever, chills, headaches, etc.-signs/symptoms develop about one week after the decrease of use.-symptoms cause impairment in important areas of functioning.-cannot be attributed to a medical condition and cannot be better described by another mental disorder, including intoxication or withdrawal of another substance.Differential Diagnosis-Other substance withdrawals-bipolar disorders-depressive disorders-another medical condition-Marijuana Craving Questionnaire, MCQ - Marijuana Withdrawal Checklist, MWCQ -The most common treatments for withdrawals is psychopharmacotherapy, specifically Benzodiazepines.-Motivational Interviewing might also be useful to help the client get through this time where he/she is experiencing difficult symptoms.-CBT-Behavioral Self-Control Training (BSCT)-Family TherapyCoding Note:-ICD-9-CM code is 292.0.-ICD-10-CM code for cannabis withdrawal is F12.288, which indicates that comorbid presence of a moderate or severe cannabis disorder.-This reflects that withdrawal can only occur with the presence of a severe or moderate cannabis use disorder.-It is not acceptable to code comorbid mild cannabis use disorder with cannabis withdrawal.Risk and Prognostic Factors-EnvironmentalUnspecified Cannabis-Related Disorder – 292.9(F12.99)Page 519DiagnosisAssessmentsTreatmentsSide NotesDiagnostic Criteria-The presence of symptoms that show characteristics of a cannabis related disorder but do not meet the full criteria for a cannabis-related disorder or other disorders in the substance-related and addictive disorders class.-This does show symptoms that cause significant impairment on important areas of functioning.DAST-20: Adolescent version (PDF 1.2MB)CRAFFTDrug Abuse Screen Test (DAST-10 (PDF, 168KB))CAGE-AID (PDF, 30KB)NIDA Drug Use Screening ToolCRAFFT (Part A)NIDA Drug Use Screening Tool: Quick Screen -Structured Interview-Unstructured Interview-Treatment would be based on the level of severity.-In this diagnosis, the client is not meeting all criteria, so it would not be as severe as some as it would be if the full criteria were met.-Some considerations would be:-Outpatient-Based Treatments-Motivational Interviewing (MI)-Cognitive Behavioral Therapy (CBT)-Behavioral Self-Control Training (BSCT)-Family Therapy-Social Skills TrainingReferencesAbuse, N. I. (2015, September 22). Chart of Evidence-Based Screening Tools for Adults and Adolescents. Retrieved July 5, 2017, from Psychiatric Association. (2013).?Diagnostic and statistical manual of mental disorders?(5th ed.). Arlington, VA: American Psychiatric Publishing.Budney, A. J., Hughes, J. R., Moore, B. A. & Novy, P. L. (2001). Marijuana abstinence effects in marijuana smokers maintained in their home environment. Archives of General Psychiatry, 58(10), 917-924. Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161(11), 1967-1977.Budney, A. J., & Moore, B. A. (2002). Development and consequences of cannabis dependence. Journal of Clinical Pharmacology, 42(11), 28S-33S.Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT Alcohol Consumption Questions (AUDIT-C): An effective brief screening test for problem drinking. Arch Internal Med. 1998 (3): 1789-1795. Heishman, S. J., Evans, R. J., Singleton, E. G., Levin, K. H., Copersino, M. L., & Gorelick, D. A. (2009). Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug and alcohol dependence, 102(1), 35-40. Kress, V. E., & Paylo, M. J. (2015).?Treating those with mental disorders: a comprehensive approach to case conceptualization and treatment. Boston: Pearson.Worcester, S. (2016, June 8). PAWSS Tool Identifies Alcohol Withdrawal Syndrome Risk. Retrieved July 05, 2017, from 520-560Hallucinogen-Related Disorders~Phencyclidine-PCP (Angel Dust), Ketamine & other substancesDiagnosis Criteria-*Clinically Significant impairment or distress occurring within 12 months*Taken in larger amounts over longer duration than intended*Persistent desire/ unsuccessful efforts to cut down*Failure to fulfill major roles/obligations*Occupational/recreational activities are reduced or give up*Used despite knowledge of physical or psychological problems ~Other Hallucinogen-MOMA (Ecstasy), Molly, LSDDiagnosis Criteria-*Clinically Significant impairment or distress occurring within 12 months*Taken in larger amounts over longer duration than intended*Persistent desire/ unsuccessful efforts to cut down*Occupational/recreational activities are reduced or give up*Used despite knowledge of physical or psychological problems *Strong cravings*Desire/ urge to use*physically hazardous~Phencyclidine Intoxication-Diagnosis Criteria-*Clinically problematic behavioral changes*Vertical/horizontal nystagmus *Hypertension *Numbness or diminished response to pain*Dysarthria *Seizures or coma ~Other Hallucinogen Intoxication-Diagnosis Criteria-*Anxiety *Depression*Paranoid*Impaired judgment*Pupillary dilation*Sweating*Palpitations*Blurred vision*Tremors*Incoordination~Hallucinogen Persisting Perception Disorder- 282.89 (F16.983)Diagnosis Criteria-*Re-experiencing one or more of perceptual symptoms experiences while intoxicated*Geometric hallucinations/false perceptions of movement*Visuals-flashes of colors, trails/imagesInhalant-Related Disorders-~Inhaled Substances-Cleaning agents. Pesticides, gasoline, glue, paint thinners, computer cleaner & felt tip pensDiagnosis Criteria-*Occurring within 12 months*Taken in larger amounts over longer duration than intended*Persistent desire/ unsuccessful efforts to cut down*Failure to fulfill major roles/obligations*Occupational/recreational activities are reduced or give up*Time spent obtaining inhalant*Strong cravings/desire to use*Physically hazardous*Continued use despite problems personally/professionally~Inhalant Intoxication-Inhalant Substance- Volatile, Hydrocarbons & Toluene or GasolineDiagnosis Criteria-*Problematic behavior*Dizziness*Nystagmus*Incoordination*Slurred speech*Unsteady gait*Lethargy*Depressed reflexes*Psychomotor retardation*Tremor*Generalized muscles weakness*Blurred vision*Stupor or coma*EuphoriaOpioid use Disorder-Natural opiates-MorphineSemisynthetic opioids-HeroinSynthetic opioids-MethadoneDiagnosis Criteria-*Occurring within 12 months*Taken in larger amounts over longer duration than intended*Persistent desire/ unsuccessful efforts to cut down*Failure to fulfill major roles/obligations*Occupational/recreational activities are reduced or give up*Time spent obtaining inhalant*Strong cravings/desire to use*NOTE- Common pathway to opioid abuse/misuse-Prescription Opioid Substances- OxyContin & Vicodin~Opioid Intoxication-Diagnosis Criteria-*Problematic Behavior*Pupillary dilation due to anoxia from server overdose*Drowsiness or coma*Slurred speech*Impairment in attention or memory~Opioid Withdrawal-292.0 (F11.23)Diagnosis Criteria- *Reduction in opioid use*Dysphoric mood*Nausea or vomiting*Muscle aches*Lacrimation or rhinorrhea*Pupillary dilation, *Piloerection*Sweating*Diarrhea*Yawning*Fever*InsomniaSedative Hypnotic or Anxiolytic use Disorder-Abused- Benzodiazepines, Barbiturates & DepressantsDiagnosis Criteria-*Problematic pattern occurring within 12 months*Taken in larger amounts over longer duration than intended*Persistent desire/ unsuccessful efforts to cut down*Failure to fulfill major roles/obligations*Occupational/recreational activities are reduced or give up*Time spent obtaining inhalant*Strong cravings/desire to use*Physically hazardous*Continued use despite problems personally/professionally~Sedative, Hypnotic or Anxiolytic Intoxication-Diagnosis Criteria-*Maladaptive behavior or psychological change*Sexual/aggressive behavior*Mood liability*Impaired judgement*Slurred speech*Incoordination*Unsteady gait*Nystagmus*Impairment in cognition (Attention & memory)~ Sedative Hypnotic or Anxiolytic Withdrawal-Diagnosis Criteria-*Developing within several hours to a few days after reduction*Autonomic hyperactivity-sweating, pulse rate greater than 100 bpm*Hand tremor*Insomnia*Nausea or vomiting*Visual, tactile, auditory hallucinations or illusions*Psychomotor agitation*Anxiety*Grand mal seizures____________________________________________________________________________ASSESSMENTS*Addiction Severity Index (ASI)*Composite International Diagnostic Interview (CHDI)*Structured Clinical Interview DSM-IV (SCID)*Psychiatric Research Interview for Substance & Mental Disorders (PRISM)*SEMI-Structured Assessment for Drug Dependency & Alcoholism (SSADDA)*Rapid Opioid Dependence Screen (RODS)TREATMENTS *Individual/ Group Counseling*Cognitive Behavior Therapy (CBT)*Family Therapy (FT)*Twelve-Step Facilitation*Motivational Interviewing (MI)*Psychopharmacothearpy & Medication-Assisted Treatment*Maintenance Therapy -Methadone & BuprenorphineTABLE 1 Addict Sci Clin Pract. 2007 Dec; 4(1): 19–31.Characteristics and Selected Assessment Categories of Six Structured Assessment InstrumentsInstrumentDiagnostic ClassificationAssessment Categories*Time Frames Covered by the AssessmentsAverage Administration Time in Psychiatric PopulationsTrainingAddiction Severity Index (ASI)??No assessment of diagnosisFunctioning in 7 domains: alcohol, drugs, psychiatric, family/social, medical, employment/support, legalLifetime, past 30 days45–60 min., plus 10–20 min. for scoringTraining manual, classroom session (2 days), competency measures administered at end of each sessionWorld Mental Health Composite International Diagnostic Interview (WMH-CIDI)?Diagnostic and Statistical Manual of Mental Disorders, 4th Edition?(DSM-IV),?International Classification of Diseases, 10th Edition?(ICD-10)DSM-IV Alcohol/Drug Abuse and DependenceICD-10 Alcohol/Drug DependenceICD-10 Harmful Use Alcohol/DrugsDSM-IV/ICD-10 Nicotine DependenceDSM-IV/ICD-10 Anxiety DisordersDSM-IV/ICD-10 Mood DisordersDSM-IV Attention Deficit DisorderDSM-IV/ICD-10 Conduct DisorderDSM-IV Intermittent Explosive DisorderDSM-IV/ICD-10 Pathological GamblingLifetime, past 12 months75 min.Home-study CDs, classroom training (2.5–3 days)Structured Clinical Interview for DSM-IV (SCID)??DSM-IVAlcohol/Drug Dependence and Abuse, Polysubstance DependenceAnxiety Disorders, Substance-Induced (S-I) Anxiety DisordersMood Disorders (Dysthymic Disorder, current only), S-I Mood DisordersAcute Stress DisorderAdjustment Disorder (current only)Personality Disorder (Axis II version§)Psychotic Disorders, S-I Psychotic DisordersSomatization Disorder (current only)Lifetime, current90 min.User’s guide, didactic recordings (11 hours), interview recordings, on-site training (1–2 days), audiotape review for quality assuranceAlcohol Use Disorders and Associated Disabilities Interview Schedule (AUDADIS)??DSM-IVAlcohol and Drug Consumption, Alcohol/Drug Abuse and DependenceTobacco Use and DependenceAnxiety Disorders, S-I Anxiety DisordersMood Disorders, S-I Mood DisordersPathological GamblingPersonality DisordersTreatment Utilization (for each diagnosis), Family History (for each diagnosis)Lifetime, past 12 monthsNo information availableNot availablePsychiatric Research Interview for Substance and Mental Disorders (PRISM)??DSM-IVAlcohol/Drug Abuse and DependenceNicotine DependenceAnxiety Disorders, S-I Panic Disorder, S-I Generalized Anxiety DisorderMood Disorders, S-I Mood DisordersAntisocial Personality Disorder, Borderline Personality DisorderPsychotic Disorders, S-I Psychotic DisordersLifetime, past 12 months, current120 min.Training manual, didactic session (2 days), audiotape review for quality assuranceSemi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA)?DSM-IVAlcohol/Drug Abuse and DependenceAntisocial Personality DisorderAttention Deficit Hyperactivity DisorderMajor Depression, Bipolar DisorderPathological GamblingPost-Traumatic Stress DisorderLifetimeNo information availableTraining manual, didactic session (3 days), audiotape review for quality assuranceNational Association for Addiction Professionals (NAADAC) of Ethics--Confidentiality- All substance abuse counselors must comply with federal and state laws-Client Relationships- All substance abuse counselors are prohibited from discriminating against clients based on race, religion, sexual orientation and political views-Dealing with the public- All substance abuse counselors are prohibited from making public statements concerning substance abuse that have not been proven factual-Client welfare- All substance abuse counselors are obligated to do everything they can to protect the welfare of clientsReferencesKress V. & Paylo M. (2015) Treating those with Mental Disorders: PearsonDSM-5 (2013) Diagnostic and Statistical Manual of Mental Disorders 5th Edition: American Psychiatric Publishing Sci Clin Pract. 2007 Dec; 4(1): 19–31. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download